Kumar Prabhash
Kumar Prabhash
Prof, Medical Oncology, Tata Memorial Hospital
Verified email at
Cited by
Cited by
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy …
EB Garon, TE Ciuleanu, O Arrieta, K Prabhash, KN Syrigos, T Goksel, ...
The Lancet 384 (9944), 665-673, 2014
Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study
GV Scagliotti, V Hirsh, S Siena, DH Henry, PJ Woll, C Manegold, ...
Journal of Thoracic Oncology 7 (12), 1823-1829, 2012
Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial
T Gupta, JP Agarwal, S Jain, R Phurailatpam, S Kannan, S Ghosh-Laskar, ...
Radiotherapy and Oncology 104 (3), 343-348, 2012
Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer
V Noronha, VM Patil, A Joshi, N Menon, A Chougule, A Mahajan, A Janu, ...
Journal of Clinical Oncology 38 (2), 124-136, 2020
Once-a-week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: a phase III randomized noninferiority trial
V Noronha, A Joshi, VM Patil, J Agarwal, S Ghosh-Laskar, A Budrukkar, ...
Journal of Clinical Oncology 36 (11), 1064-1072, 2018
Prostate-only versus whole-pelvic radiation therapy in high-risk and very high-risk prostate cancer (POP-RT): outcomes from phase III randomized controlled trial
V Murthy, P Maitre, S Kannan, G Panigrahi, R Krishnatry, G Bakshi, ...
Journal of Clinical Oncology 39 (11), 1234-1242, 2021
Crizotinib: A comprehensive review
A Sahu, K Prabhash, V Noronha, A Joshi, S Desai
South Asian journal of cancer 2 (2), 91, 2013
Epidemiology of lung cancer in India: Focus on the differences between non-smokers and smokers: A single-centre experience
V Noronha, R Dikshit, N Raut, A Joshi, CS Pramesh, K George, ...
Indian journal of cancer 49 (1), 74-81, 2012
The Chennai Declaration: a roadmap to tackle the challenge of antimicrobial resistance
A Ghafur, D Mathai, A Muruganathan, JA Jayalal, R Kant, D Chaudhary, ...
Indian Journal of Cancer 50 (1), 71-73, 2013
Weekly low‐dose versus three‐weekly high‐dose cisplatin for concurrent chemoradiation in locoregionally advanced non‐nasopharyngeal head and neck cancer: a systematic review …
P Szturz, K Wouters, N Kiyota, M Tahara, K Prabhash, V Noronha, ...
The oncologist 22 (9), 1056-1066, 2017
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial
M Schuler, JCH Yang, K Park, JH Kim, J Bennouna, YM Chen, C Chouaid, ...
Annals of Oncology 27 (3), 417-423, 2016
Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non‐small cell lung cancer or colorectal cancer: a randomized, double‐blind, placebo …
AJ Stewart Coats, GF Ho, K Prabhash, S von Haehling, J Tilson, R Brown, ...
Journal of cachexia, sarcopenia and muscle 7 (3), 355-365, 2016
Neoadjuvant chemotherapy followed by surgery in very locally advanced technically unresectable oral cavity cancers
VM Patil, K Prabhash, V Noronha, A Joshi, V Muddu, S Dhumal, S Arya, ...
Oral oncology 50 (10), 1000-1004, 2014
Frequency of EGFR Mutations in 907 Lung Adenocarcioma Patients of Indian Ethnicity
A Chougule, K Prabhash, V Noronha, A Joshi, A Thavamani, P Chandrani, ...
PloS one 8 (10), e76164, 2013
Actionable activating oncogenic ERBB2/HER2 transmembrane and juxtamembrane domain mutations
KB Pahuja, TT Nguyen, BS Jaiswal, K Prabhash, TM Thaker, K Senger, ...
Cancer cell 34 (5), 792-806. e5, 2018
Lung cancer in the Indian subcontinent
V Noronha, R Pinninti, VM Patil, A Joshi, K Prabhash
South Asian journal of cancer 5 (03), 095-103, 2016
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer
VM Patil, V Noronha, A Joshi, J Agarwal, S Ghosh‐Laskar, A Budrukkar, ...
Cancer 125 (18), 3184-3197, 2019
Consensus recommendations for management of head and neck cancer in Asian countries: a review of international guidelines
A D’cruz, T Lin, AK Anand, D Atmakusuma, MJ Calaguas, I Chitapanarux, ...
Oral oncology 49 (9), 872-877, 2013
Blood stream infections in cancer patients: a single center experience of isolates and sensitivity pattern.
K Prabhash, A Medhekar, N Ghadyalpatil, V Noronha, S Biswas, ...
Indian journal of cancer 47 (2), 2010
Low-dose vs. high-dose cisplatin: lessons learned from 59 chemoradiotherapy trials in head and neck cancer
P Szturz, K Wouters, N Kiyota, M Tahara, K Prabhash, V Noronha, ...
Frontiers in oncology 9, 86, 2019
The system can't perform the operation now. Try again later.
Articles 1–20